A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

Clinical trial NCT07719361 · RECRUITING

Trial details

NCT number: NCT07719361
Sponsor: Flare Therapeutics Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Castration Resistant Prostate Cancer mCRPC mCRPC (Metastatic Castration-resistant Prostate Cancer)Prostatic Neoplasms Prostatic Neoplasms, Castration-Resistant mCRPC or Advanced/Metastatic Solid Tumors mCRPC, Metastatic Castration Resistant Prostate Cancer Neoplasms Prostate Neoplasms of Prostate

Start date: 2026-07-01
Primary completion: 2028-02-15
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.